# Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis

> **NCT00086684** · PHASE4 · TERMINATED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 369 (actual)

## Conditions studied

- Interstitial Cystitis

## Interventions

- **DRUG:** Pentosan polysulfate sodium 100 mg
- **DRUG:** Placebo
- **DRUG:** Pentosan polysulfate sodium 100 mg

## Key facts

- **NCT ID:** NCT00086684
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-09
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 369 (ACTUAL)
- **Why stopped:** Interim Analysis showed that study continuation was futile. No safety concerns were raised during the trial.
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00086684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00086684, "Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00086684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*